Research on scleroderma highlights that certain factors significantly increase the likelihood of developing this condition. Identifying these risk factors is crucial for understanding why some individuals are more prone to scleroderma. By focusing on these factors, researchers aim to develop better strategies for early detection and management, potentially leading to improved outcomes for those affected.
Further research is needed to fully understand these risk factors and their contribution to scleroderma's development. This ongoing investigation could lead to more effective treatments and better patient care. The study's findings emphasize the importance of continued research in this area, as noted by Navaneeth and Karthikeyan (2025).
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: